SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 63 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $26,222,000 | -63.7% | 14,365,000 | -51.3% | 0.17% | -64.1% |
| Q3 2014 | $72,236,000 | -30.5% | 29,516,000 | -44.3% | 0.48% | -26.9% |
| Q2 2014 | $103,949,000 | -9.9% | 52,965,000 | -22.5% | 0.66% | -10.6% |
| Q1 2014 | $115,311,000 | +9.1% | 68,318,000 | -3.0% | 0.74% | +9.7% |
| Q4 2013 | $105,713,000 | +4.6% | 70,422,000 | -14.0% | 0.67% | +6.0% |
| Q3 2013 | $101,055,000 | +1.8% | 81,844,000 | -1.4% | 0.63% | -2.3% |
| Q2 2013 | $99,291,000 | – | 83,000,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $4,916,000 | 4.33% |
| SYMPHONY ASSET MANAGEMENT LLC | 19,840,000 | $38,948,000 | 4.05% |
| SILVERBACK ASSET MANAGEMENT LLC | 19,709,000 | $38,695,000 | 4.00% |
| MACKAY SHIELDS LLC | 31,471,000 | $61,916,000 | 3.41% |
| Sage Capital Management, LLC | 1,500,000 | $2,942,000 | 2.98% |
| ALTEGRIS ADVISORS, L.L.C. | 250,000 | $491,000 | 2.56% |
| Wellesley Asset Management | 16,220 | $31,923,000 | 2.01% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $16,883,000 | 1.62% |
| CAMDEN ASSET MANAGEMENT L P /CA | 13,862,000 | $27,213,000 | 1.58% |
| Calamos Wealth Management LLC | 2,061,000 | $4,045,000 | 1.15% |